Table 1.

Patient characteristics

Number of patientsTotal40
Evaluable38
Median (range) age54 (39, 78)
Performance status0:1:24:30:6
Race (White/Asian/Unknown)28:11:1
Prior regimens, n1:2:324:12:4
Prior therapyRadiotherapy13
Adjuvant chemotherapy26
Systemic chemotherapy19
Median (range) Cycles/patient4 (1, 20)
Total cycles208
Best responsePR confirmed2 (5%)
PR unconfirmed1 (2.5%)
Stable disease (SD)26 (65%)
Progressive disease (PD)9 (22.5%)
Not evaluable2 (5%)
PFS ≥ 6 months8 (1 PR + 7 SD) 21%